Ascendis Pharma A/S ASND
Set alert
248.98 USD -2.29 -0.91%
At close · Nov 2
248.98 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
248.68 Day range 253.71
188.07 52-week range 282.15
- YTD
- +16.76%
- 1 year
- +23.50%
- Open
- 252.55
- Prev close
- 251.27
- Mkt cap
- 16.38B
- Vol
- 479.91K
- Avg vol
- 703.07K
- EPS
- 12.93
- P/E
- 19.26
- Div yield
- 0.00%
More statistics
- Low
- 248.68
- High
- 253.71
- Forward P/E
- 24.90
- Beta
- 0.00
- Short ratio
- 3.27
- Inst. own
- 103.67%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2026
- 50-d avg
- 242.31
- 200-d avg
- 238.10
- 1y target
- 304.67
5D chart
Signals (122)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 9:30 AM | 14 hours ago |
| SMA: Bullish | Oct 30, 3:45 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:30 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:15 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:10 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:35 PM | 3 days ago |
| RSI: Oversold | Oct 30, 1:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 1:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:30 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:00 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 12:55 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:25 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:15 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:15 PM | 3 days ago |
Newest 20 of 122.
Financial health
Altman Z-Score
10.23 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 2
- P/E 3
- P/B 1
Valuation
P/E -50.1×
FY 2016 5y median -16.9× FY 2025
P/S 15.9×
FY 2016 5y median 24.0× FY 2025
P/B -67.6×
FY 2016 5y median -44.0× FY 2025
P/FCF 252×
FY 2016 5y median -13.7× FY 2025
EV/EBITDA -103×
FY 2016 5y median -17.1× FY 2025
EV/Sales 16.3×
FY 2016 5y median 25.4× FY 2025
FCF Yield 0.4%
FY 2016 5y median -6.8% FY 2025
Profitability
Gross Margin 85.1%
FY 2016 5y median 83.4% FY 2025
Operating Margin -18.9%
FY 2016 5y median -170.8% FY 2025
Net Margin -31.7%
FY 2016 5y median -180.5% FY 2025
ROE 134.6%
FY 2016 5y median 134.6% FY 2025
ROIC -18.2%
FY 2016 5y median -45.2% FY 2025
ROA -16.8%
FY 2016 5y median -35.4% FY 2025
Growth (YoY)
Revenue 90.2%
FY 2016 FY 2025
Operating Income 53.0%
FY 2016 FY 2025
EPS (diluted) 44.6%
FY 2016 FY 2025
Free Cash Flow 114.2%
FY 2016 FY 2025
Financial Health
Current Ratio 1.0×
FY 2016 5y median 1.2× FY 2025
Quick Ratio 0.8×
FY 2016 5y median 0.8× FY 2025
Debt / Equity -5.4×
FY 2016 5y median -5.1× FY 2025
Net Debt / EBITDA -2.3×
FY 2016 5y median -0.9× FY 2025
Interest Coverage -1.7×
FY 2016 5y median -10.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
